Alpha 2.0
Login Register
» Articles » PMID: 31820474

Carbon Monoxide: An Emerging Therapy for Acute Kidney Injury

Overview
Journal Med Res Rev
Publisher Wiley
Specialties General Medicine
Pharmacology
Date 2019 Dec 11
PMID 31820474
Citations 31
Authors
Xiaoxiao Yang
Mark de Caestecker
Leo E Otterbein
Binghe Wang
Affiliations
Soon will be listed here.
Abstract

Treating acute kidney injury (AKI) represents an important unmet medical need both in terms of the seriousness of this medical problem and the number of patients. There is also a large untapped market opportunity in treating AKI. Over the years, there has been much effort in search of therapeutics with minimal success. However, over the same time period, new understanding of the underlying pathobiology and molecular mechanisms of kidney injury have undoubtedly helped the search for new therapeutics. Along this line, carbon monoxide (CO) has emerged as a promising therapeutic agent because of its demonstrated cytoprotective, and immunomodulatory effects. CO has also been shown to sensitize cancer, but not normal cells, to chemotherapy. This is particularly important in treating cisplatin-induced AKI, a common clinical problem that develops in patients receiving cisplatin therapies for a number of different solid organ malignancies. This review will examine and make the case that CO be developed into a therapeutic agent against AKI.

Citing Articles

Carbon Monoxide as a Potential Therapeutic Agent: A Molecular Analysis of Its Safety Profiles.

Bansal S, Liu D, Mao Q, Bauer N, Wang B J Med Chem. 2024; 67(12):9789-9815.

PMID: 38864348 PMC: 11215727. DOI: 10.1021/acs.jmedchem.4c00823.

Fluorescent small molecule donors.

Chen G, Yu J, Wu L, Ji X, Xu J, Wang C Chem Soc Rev. 2024; 53(12):6345-6398.

PMID: 38742651 PMC: 11181996. DOI: 10.1039/d3cs00124e.

On the Question of CO's Ability to Induce HO-1 Expression in Cell Culture: A Comparative Study Using Different CO Sources.

Yang X, Mao Q, Wang B ACS Chem Biol. 2024; 19(3):725-735.

PMID: 38340055 PMC: 10949199. DOI: 10.1021/acschembio.3c00750.

Molecular Mechanisms of Oxidative Stress in Acute Kidney Injury: Targeting the Loci by Resveratrol.

Rashid H, Jali A, Akhter M, Abdi S Int J Mol Sci. 2024; 25(1).

PMID: 38203174 PMC: 10779152. DOI: 10.3390/ijms25010003.

Energy metabolic reprogramming regulates programmed cell death of renal tubular epithelial cells and might serve as a new therapeutic target for acute kidney injury.

Zhao L, Hao Y, Tang S, Han X, Li R, Zhou X Front Cell Dev Biol. 2023; 11:1276217.

PMID: 38054182 PMC: 10694365. DOI: 10.3389/fcell.2023.1276217.

References
1.
Ji X, Pan Z, Li C, Kang T, De La Cruz L, Yang L . Esterase-Sensitive and pH-Controlled Carbon Monoxide Prodrugs for Treating Systemic Inflammation. J Med Chem. 2019; 62(6):3163-3168. DOI: 10.1021/acs.jmedchem.9b00073. View
2.
Mayr F, Spiel A, Leitner J, Marsik C, Germann P, Ullrich R . Effects of carbon monoxide inhalation during experimental endotoxemia in humans. Am J Respir Crit Care Med. 2004; 171(4):354-60. DOI: 10.1164/rccm.200404-446OC. View
3.
McLean S, Mann B, Poole R . Sulfite species enhance carbon monoxide release from CO-releasing molecules: implications for the deoxymyoglobin assay of activity. Anal Biochem. 2012; 427(1):36-40. DOI: 10.1016/j.ab.2012.04.026. View
4.
Bracken W, Sharma R, Bourcier D . Cellular distribution of inorganic mercury and its relation to cytotoxicity in bovine kidney cell cultures. J Toxicol Environ Health. 1984; 13(4-6):865-77. DOI: 10.1080/15287398409530547. View
5.
De La Cruz L, Benoit S, Pan Z, Yu B, Maier R, Ji X . Click, Release, and Fluoresce: A Chemical Strategy for a Cascade Prodrug System for Codelivery of Carbon Monoxide, a Drug Payload, and a Fluorescent Reporter. Org Lett. 2018; 20(4):897-900. DOI: 10.1021/acs.orglett.7b03348. View